Professional perspective
Clinical relevance
- Differential diagnostic exclusion of other pain causes before diagnosis
- Ingredient- and formulation-specific selection of home and in-office measures, considering mechanism of action, evidence base, and clinical situation
- Identifying and addressing underlying risk factors (erosion, abrasion, recession, periodontitis)
- Patient education on realistic timeframes to effect
Prevalence
A European population-based cross-sectional study (West, Sanz, Lussi, Bartlett, Bouchard, Bourgeois, 2013) examined 3,187 adults aged 18 to 35 from general dental practices in France, Spain, Italy, the United Kingdom, Finland, Latvia, and Estonia. Dentin hypersensitivity was assessed clinically using cold-air stimulation combined with patient and examiner evaluation; approximately one third of the study population met the criteria. Erosive tooth wear (BEWE index) and gingival recession were significantly associated with the presence of dentin hypersensitivity. Published prevalence figures for dentin hypersensitivity overall vary considerably, since studies use different populations, case definitions, and assessment methods.
Differential diagnosis
Dentin hypersensitivity is a diagnosis of exclusion. Caries, pulpitis, enamel cracks, leaking or fractured restorations, postoperative symptoms, and occlusal trauma can produce similar symptoms and must be ruled out before diagnosis. The underlying dentin exposure frequently results from the interplay of several processes, such as gingival recession combined with erosion or abrasion.
Management: active ingredients and efficacy
A systematic review with follow-up analysis (Marto et al., 2019) evaluated 74 randomized controlled trials involving 5,366 patients and at least 9,167 teeth, and ranked the reported efficacy of various active ingredients by the follow-up periods used in the included studies. At follow-up periods up to 7 days, glutaraldehyde with HEMA, glass ionomer cements, and laser showed significant reductions. At follow-up periods up to 1 month, stannous fluoride and hydroxyapatite also proved effective. At longer follow-up periods, potassium nitrate, arginine, glutaraldehyde with HEMA, hydroxyapatite, adhesive systems, glass ionomer cements, and laser showed significant reductions. These differing follow-up periods primarily reflect differences between the included studies, such as formulation, concentration, study protocol, comparator, and measurement method, and do not establish a universal onset of action inherent to any given active ingredient. Onset and magnitude of relief can vary by active ingredient, formulation, application method, and individual response.
Two major therapeutic strategies are distinguished mechanistically: reducing nerve excitability (for example, potassium nitrate) and occluding open dentin tubules (for example, stannous fluoride, arginine-calcium carbonate, hydroxyapatite, bioactive glass particles, adhesive systems). Depending on the clinical situation and response to home care, in-office options may include varnishes, sealants, adhesive systems, or laser-based approaches, particularly for pronounced or treatment-resistant symptoms.
What current evidence supports
- Dentin hypersensitivity as a diagnosis of exclusion, with exposed dentin and open dentin tubules as the central structural mechanism
- Multiple active ingredient classes with efficacy demonstrated in randomized controlled trials against control conditions
- An association between erosive processes or recession and the presence of dentin hypersensitivity
Why this matters
Sensitivity is a symptom, not a diagnosis by itself. Treating every sensitive tooth routinely with a desensitizing product can mean caries, cracks, pulpal disease, restoration problems, or other causes of pain go unrecognized.
What the data currently doesn't show
- No uniform, standardized prevalence definition that reliably allows direct comparison across studies
- Limited direct head-to-head comparisons between different active ingredient classes under identical study conditions
- No reliable individual prediction of which active ingredient will work fastest or most durably for a given person
- No basis for assuming that efficacy demonstrated for one formulation can be transferred to every product containing the same active ingredient
Evidence summary
West, Sanz, Lussi, Bartlett, Bouchard, Bourgeois (2013): Prevalence of dentine hypersensitivity and study of associated factors: A European population-based cross-sectional study. Journal of Dentistry, 41(10), 841-851. Population-based cross-sectional study; 3,187 adults from seven European countries.
Marto, Baptista Paula, Nunes, et al. (2019): Evaluation of the efficacy of dentin hypersensitivity treatments, a systematic review and follow-up analysis. Journal of Oral Rehabilitation, 46(10), 952-990. Systematic review; 74 RCTs, 5,366 patients, efficacy ranked by follow-up period.